Showing 1 - 10 of 19
Persistent link: https://www.econbiz.de/10001514878
Persistent link: https://www.econbiz.de/10001618683
Motivated by differences in R&D productivity across advanced economies, this paper presents an empirical examination of the determinants of country-level production of international patents. We introduce a novel framework based on the concept of national innovative capacity. National innovative...
Persistent link: https://www.econbiz.de/10012470861
European countries do less research than Japan and the United States. We use a quantitative multi-country growth model to ask: (i) Why is this so? (ii) Would there be any benefit to expanding research in Europe? (iii) What would various European research promotion policies do? We find that (i)...
Persistent link: https://www.econbiz.de/10012471984
This paper examines R&D activities in the European Community using the Community R&D Information Service (CORDIS) databases. We find that a country's private companies tend to be specialized in the same scientific fields as its universities and public organizations. In addition, we construct...
Persistent link: https://www.econbiz.de/10012472777
How do import tariffs and R&D subsidies help domestic firms compete globally? How do these policies affect aggregate growth and economic welfare? To answer these questions, we build a dynamic general equilibrium growth model where firm innovation endogenously determines the dynamics of...
Persistent link: https://www.econbiz.de/10012453173
We study the optimal allocation of R&D resources in an endogenous growth model with an innovation network, through which one sector's past innovations may benefit other sectors' future innovations. First, we provide closed-form sufficient statistics for the optimal path of R&D resource...
Persistent link: https://www.econbiz.de/10012794633
By thoroughly controlling for the country covariates, through a combination of matched sampling techniques with fixed-effect panel regression models, the analyses arrive at robust results across the various model specifications. First, national pharmaceutical patent protection alone does not...
Persistent link: https://www.econbiz.de/10012462357
Getting science policy right is a core objective of government that bears on scientific advance, economic growth, health, and longevity. Yet the process of science is changing. As science advances and knowledge accumulates, ensuing generations of innovators spend longer in training and become...
Persistent link: https://www.econbiz.de/10012462651